AVSF - Integrated Biosciences 2026, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Nov 5, 2026, it has sold $261,500 of interests to 18 investors since its first sale in Oct 2026. The minimum investment it accepts from an outside investor is $5,000. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Michael Collins.
- Total raised
- $261,500Cumulative sales reported on Form D
- Investors
- 18
- First sale
- Oct 24, 2026
- Minimum investment
- $5,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Nov 5, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - Integrated Biosciences 2026, LLC
What is the minimum investment for AVSF - Integrated Biosciences 2026, LLC?
According to its latest Form D, filed Nov 5, 2026, the minimum investment AVSF - Integrated Biosciences 2026, LLC accepts from an outside investor is $5,000.
Who can invest in AVSF - Integrated Biosciences 2026, LLC?
AVSF - Integrated Biosciences 2026, LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - Integrated Biosciences 2026, LLC raised?
AVSF - Integrated Biosciences 2026, LLC reports $261,500 sold from 18 investors on its Form D filed Nov 5, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - Integrated Biosciences 2026, LLC based?
AVSF - Integrated Biosciences 2026, LLC is based in Boston, Massachusetts.
When did AVSF - Integrated Biosciences 2026, LLC launch?
AVSF - Integrated Biosciences 2026, LLC reports its first sale in Oct 2026, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 43% of the 533 venture capital funds based in Massachusetts, and more than 36% of all 14,877 that report sales.